Vulvar cancer

Vulvar cancer is a rare condition, accounting for 4% of gynecological cancers and less than 1% of all female cancers.We conducted a retrospective descriptive study of 30 observations of vulvar cancer collected in the Obstetrics and Gynecology Department of Monastir over a period of 16 years. The objectives were to describe the epidemiologic-clinical profile and specify the therapeutic modalities of vulvar cancer.The average age of patients was 70 years. The average delay to consultation was 7 months. Clinical symptoms were dominated by pruritus and the perception of a vulvar tumour. Ulcerative-bourgeous forms accounted for 50% of cases. Multifocal involvement was the most frequent, with a mean size of 4 cm.Overall survival at 5 years was 72.2%.Preventing vulvar cancer through early detection of at-risk groups and precancerous lesions remains the best way of combating this disease.

Autorentext
Associate Professor of Obstetrics and Gynaecology.Teacher at the Faculty of Medicine of Monastir and sousse and the School of Health.